These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 6751732)
41. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Nesto RW Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526 [TBL] [Abstract][Full Text] [Related]
42. Lipoprotein metabolism in pregnancy, fat transport to the fetus, and the effects of diabetes. Knopp RH; Warth MR; Charles D; Childs M; Li JR; Mabuchi H; Van Allen MI Biol Neonate; 1986; 50(6):297-317. PubMed ID: 3542067 [TBL] [Abstract][Full Text] [Related]
43. Lipoprotein lipid and protein responses to dietary fat and diabetes in rats. Hennig B; Dupont J J Nutr; 1983 Oct; 113(10):1984-94. PubMed ID: 6225845 [TBL] [Abstract][Full Text] [Related]
46. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Chaturvedi N; Fuller JH; Taskinen MR; Diabetes Care; 2001 Dec; 24(12):2071-7. PubMed ID: 11723085 [TBL] [Abstract][Full Text] [Related]
47. Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians. Howard BV Diabetes Care; 1993 Jan; 16(1):284-91. PubMed ID: 8422793 [TBL] [Abstract][Full Text] [Related]
48. Postprandial hyperlipidemia as a potential residual risk factor. Nakamura K; Miyoshi T; Yunoki K; Ito H J Cardiol; 2016 Apr; 67(4):335-9. PubMed ID: 26744235 [TBL] [Abstract][Full Text] [Related]
49. [Disorders of lipid metabolism in diabetes mellitus]. Biesenbach G Wien Med Wochenschr Suppl; 1989; 105():9-17. PubMed ID: 2694631 [TBL] [Abstract][Full Text] [Related]
50. 2017 Taiwan lipid guidelines for high risk patients. Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI; J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176 [TBL] [Abstract][Full Text] [Related]
51. Effects of various lipid-lowering treatments in diabetics. Steiner G J Cardiovasc Pharmacol; 1990; 16 Suppl 9():S35-9. PubMed ID: 1710744 [TBL] [Abstract][Full Text] [Related]
52. Lipids and atherogenesis in diabetes mellitus. Betteridge DJ Atherosclerosis; 1996 Jul; 124 Suppl():S43-7. PubMed ID: 8831915 [TBL] [Abstract][Full Text] [Related]
53. Changes in lipoprotein concentrations during the development of noninsulin-dependent diabetes mellitus in obese rhesus monkeys (Macaca mulatta). Hannah JS; Verdery RB; Bodkin NL; Hansen BC; Le NA; Howard BV J Clin Endocrinol Metab; 1991 May; 72(5):1067-72. PubMed ID: 2022707 [TBL] [Abstract][Full Text] [Related]
54. Diabetes and hyperlipidemia correlate with gallbladder contractility in leptin-related murine obesity. Tran KQ; Goldblatt MI; Swartz-Basile DA; Svatek C; Nakeeb A; Pitt HA J Gastrointest Surg; 2003 Nov; 7(7):857-62; discussion 863. PubMed ID: 14592658 [TBL] [Abstract][Full Text] [Related]
55. Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia. Briones ER; Steiger DL; Palumbo PJ; O'Fallon WM; Langworthy AL; Zimmerman BR; Kottke BA Am J Clin Nutr; 1986 Sep; 44(3):353-61. PubMed ID: 3751956 [TBL] [Abstract][Full Text] [Related]
56. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes. Quispe R; Martin SS; Jones SR Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278 [TBL] [Abstract][Full Text] [Related]
57. [Lipid disorders in non-insulin dependent diabetes--principles of treatment]. Idzior-WaluĊ B Przegl Lek; 1996; 53(9):653-9. PubMed ID: 8992531 [TBL] [Abstract][Full Text] [Related]
58. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome. Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374 [TBL] [Abstract][Full Text] [Related]
59. Drug treatment of combined hyperlipidemia. Wierzbicki AS; Mikhailidis DP; Wray R Am J Cardiovasc Drugs; 2001; 1(5):327-36. PubMed ID: 14728015 [TBL] [Abstract][Full Text] [Related]
60. Lipid-lowering therapy and macrovascular disease in diabetes mellitus. Garg A Diabetes; 1992 Oct; 41 Suppl 2():111-5. PubMed ID: 1526329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]